Published in
Wiley, British Journal of Dermatology, 6(185), p. 1186-1199, 2021
DOI: 10.1111/bjd.20604
Links
Tools
High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma*
Journal article published in 2021 by
D. Westphal 
,
M. Garzarolli,
M. Sergon ,
P. Horak ,
B. Hutter ,
J. C. Becker,
M. Wiegel,
E. Maczey,
S. Blum ,
S. Grosche‐Schlee,
A. Rütten,
S. Ugurel ,
A. Stenzinger ,
H. Glimm ,
D. Aust
and other authors.
,
M. Garzarolli,
M. Sergon ,
P. Horak ,
B. Hutter ,
J. C. Becker,
M. Wiegel,
E. Maczey,
S. Blum ,
S. Grosche‐Schlee,
A. Rütten,
S. Ugurel ,
A. Stenzinger ,
H. Glimm ,
D. Aust
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 